ロード中...
Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes
There is a clinical imperative to improve metabolic control in the treatment of patients with type 1 diabetes, but in doing so, hypoglycemia should be avoided at all costs. Insulin analogues and the assumption they would better mimic the pharmacokinetic profile of endogenous insulin secretion emerge...
保存先:
| 出版年: | Diabetol Metab Syndr |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4426553/ https://ncbi.nlm.nih.gov/pubmed/25964802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-015-0033-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|